Halozyme Therapeutics

HALO • NASDAQ • Stock Fundamentals

Halozyme Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Helen I. Torley, with a market cap of $8.4B.

Market Cap$8.4B

Employees373.0

CEOHelen I. Torley

CountryUnited States of America

Healthcare

Biotechnology

Most Recent EarningsMay 11, 2026 · 1 month 3 days agoQ1 2026

Next EarningsAug 4, 2026 · in 2 monthsAfter Market Close · Q2 2026

Financials

Based on Q1 2026 filing

Common questions about Halozyme Therapeutics

Halozyme Therapeutics (HALO) has a market capitalization of $8.4B and trades on NASDAQ.

Halozyme Therapeutics has approximately 373 employees.